Fiche publication
Date publication
janvier 2022
Journal
Frontiers in oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BOIDOT Romain
Tous les auteurs :
Dalens L, Niogret J, Kaderbhai CG, Boidot R
Lien Pubmed
Résumé
Non-small-cell lung cancer (NSCLC) is one of the main causes of death by cancer worldwide. With the rise of targeted therapies, the search for molecular abnormalities is becoming a crucial step in the management of lung cancer. Whole exome sequencing (WES) is developing rapidly and is now accessible in routine care. However, its value, compared to smaller gene panels, remains unclear.
Mots clés
exome analysis, large NGS panel, lung adenocarcinoma, small NGS panel, utility
Référence
Front Oncol. 2022 ;12:863057
